Form 8-K - Current report:
SEC Accession No. 0000950170-25-093906
Filing Date
2025-07-03
Accepted
2025-07-03 16:30:15
Documents
10
Period of Report
2025-07-01
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K beam-20250701.htm   iXBRL 8-K 41078
  Complete submission text file 0000950170-25-093906.txt   142501

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT beam-20250701.xsd EX-101.SCH 23858
12 EXTRACTED XBRL INSTANCE DOCUMENT beam-20250701_htm.xml XML 4518
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39208 | Film No.: 251105923
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)